Medical Advocates
Pegylated Interferons
    Main Page

New and Noteworthy
 General HBV Studies
 General HCV Studies
General HIV/HCV Studies
Peg Interferon Alfa 2a
Peg Interferon Alfa 2b



 

  
Peg Inf alfa 2a Main Main New/Newsworthy Home Page
Last Update:  September 04, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
August
 
.July 2008
 
General HBV Studies
     
     Journal Papers, Abstracts, and Commentaries
 
  Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who
have failed treatment.
Sarin SK, Kumar M, Hissar S, Sharma BC.
Hepatobiliary Pancreat Dis Int. 2006 Aug;5(3):374-80
 Abstract
 
Pegylated interferon alpha in the treatment of chronic hepatitis B in HBe negative patients
Pawlowska M, Halota W.
Przegl Epidemiol. 2006;60(1):105-8.
 Abstract
 
Pegylated interferons for chronic hepatitis B
Craxi A, Cooksley WG.
Antiviral Res. 2003 Oct;60(2):87-9.
 Abstract
General HIV/HCV Studies
     
     Journal Papers, Abstracts, and Commentaries
 
 
HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment
is associated with virologic relapse.
 de Felipe B, Leal M, Soriano-Sarabia N, et al 
J Viral Hepat. 2008 Aug 28.
 Abstract

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated
with abacavir.
 Vispo E, Barreiro P, Pineda JA, et al 
Antivir Ther. 2008;13(3):429-37|
 Abstract

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected
patients failing a previous standard interferon-based regimen.
 Crespo M, Mira JA, Pineda JA, et al  
 J Antimicrob Chemother. 2008 Jun 21.
 Abstract

The use of trough ribavirin concentration to predict sustained virological response and
haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and
pegylated interferon.
 Marucco DA, de Requena DG, Bonora S, Tet al 
J Antimicrob Chemother. 2008 Jan 31
Abstract
 
Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in
HIV/Hepatitis C Virus-Coinfected Patients.
 Valerio L, Yazdanpanah Y, Poizot-Martin I, et al  
J Acquir Immune Defic Syndr. 2007 Oct 11
Abstract
 
Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection:
a research synthesis.
 Shire NJ, Welge JA, Sherman KE.
J Viral Hepat. 2007 Apr;14(4):239-48.
 Abstract
 
     Conference Reports, Abstracts, and Posters 
 
 
POSTER
 Efficacy of Pegylated Interferon + Ribavirin Treatment in HIV/HCV-co-infected Patients
Receiving Abacavir + Lamivudine or Tenofovir + either Lamivudine or Emtricitabine as
Nucleoside Analogue Backbone
 J Mira, L Lopez-Cortes, P Barreiro, et al
(15th CROI)
 PDF Poster     Abstract

POSTER
Antiretroviral Regimens including Tenofovir or Stavudine + Lamivudine as NRTI Backbone
Are Associated with Higher Sustained Virological Response Rate to Pegylated Interferon
and Ribavirin Treatment in HIV/HCV-co-infected Patients
 J. Mira, R Carrillo-Gómez, A Gutierrez
 15th CROI
PDF Poster     Abstract

Peg Inf alfa 2a Main Main New/Newsworthy Home Page

Pegylated Interferons